Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab

By Folkmane I.   Bicans J.   Amerika D.   Chapenko S.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3209-3210

Elsevier

Access to resources Recommend Favorite

Efficacy of OKT3 as Primary Therapy for Histologically Confirmed Acute Renal Allograft Rejection in Simultaneous Kidney and Pancreas Transplant Recipients

By Peddi V.R.   Kamath S.   Schroeder T.J.   Munda R.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 285-287

Elsevier

Access to resources Recommend Favorite

Neoral vs Sandimmun: Interim Results of a Randomized Trial of Efficacy and Safety in Preventing Acute Rejection in New Renal Transplant Recipients

By U.K. Neoral Study Group   Lodge J.P.A.   Pollard S.G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 272-273

Elsevier

Access to resources Recommend Favorite

Evaluation of Acute Kidney Rejection in 230 Renal Transplant Recipients

By Khajehmugehi A.R.   Mehrsai A.R.   Taheri M.   Khan Z.H.  

Transplantation Proceedings, Vol. 30, Iss. 3, 1998-05 ,pp. : 730-731

Elsevier

Access to resources Recommend Favorite

Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months

By Kandus A.   Kovac D.   Buturovic-Ponikvar J.   Ponikvar R.   Koselj M.   Lindic J.   Kmetec A.   Bren A.F.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3207-3208

Elsevier

Access to resources Recommend Favorite